Jazz Pharmaceuticals (JAZZ) Insider Trading & Ownership $111.77 -0.31 (-0.28%) As of 12:37 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Jazz Pharmaceuticals (NASDAQ:JAZZ) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.30%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$9.99MNumber OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$5.46M Get JAZZ Insider Trade Alerts Want to know when executives and insiders are buying or selling Jazz Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address JAZZ Insider Buying and Selling by Quarter Jazz Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails7/1/2025Bruce C CozaddCEOSell1,000$107.63$107,630.00 6/2/2025Bruce C CozaddCEOSell500$107.90$53,950.00 5/12/2025Seamus MulliganDirectorBuy1,621$103.00$166,963.00 5/9/2025Seamus MulliganDirectorBuy100,000$98.26$9,826,000.00 5/1/2025Bruce C CozaddCEOSell1,000$116.35$116,350.00 4/1/2025Bruce C CozaddCEOSell1,500$123.75$185,625.00 3/10/2025Patricia CarrCAOSell1,140$137.81$157,103.40 3/10/2025Robert IannoneCMOSell2,403$138.41$332,599.23 3/7/2025Robert IannoneCMOSell7,080$138.60$981,288.00 3/3/2025Bruce C CozaddCEOSell6,500$144.25$937,625.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 2/27/2025Neena M PatilEVPSell3,800$144.87$550,506.00 2/27/2025Patricia CarrCAOSell4,813$144.42$695,093.46 2/3/2025Bruce C CozaddCEOSell1,500$122.31$183,465.00 1/2/2025Bruce C CozaddCEOSell1,500$123.43$185,145.00 12/2/2024Bruce C CozaddCEOSell2,000$121.17$242,340.00 12/2/2024Patricia CarrCAOSell53$122.49$6,491.97 11/8/2024Neena M PatilEVPSell3,700$123.41$456,617.00 11/1/2024Bruce C CozaddCEOSell1,000$110.84$110,840.00 9/6/2024Mary Elizabeth HendersonSVPSell1,410$108.30$152,703.00 (Data available from 1/1/2013 forward) JAZZ Insider Trading Activity - Frequently Asked Questions Who is on Jazz Pharmaceuticals' Insider Roster? The list of insiders at Jazz Pharmaceuticals includes Bruce C Cozadd, Finbar Larkin, Jennifer E Cook, Kenneth W O'keefe, Kim Sablich, Mark Douglas Smith, Mary Elizabeth Henderson, Neena M Patil, Patricia Carr, Patrick G Enright, Peter Gray, Philip L Johnson, Renee D Gala, Rick E Winningham, Robert Iannone, Samantha Pearce, and Seamus Mulligan. Learn more on insiders at JAZZ. What percentage of Jazz Pharmaceuticals stock is owned by insiders? 4.30% of Jazz Pharmaceuticals stock is owned by insiders. Learn more on JAZZ's insider holdings. Which Jazz Pharmaceuticals insiders have been buying company stock? The following insiders have purchased JAZZ shares in the last 24 months: Philip L Johnson ($1,435,800.00), and Seamus Mulligan ($9,992,963.00). How much insider buying is happening at Jazz Pharmaceuticals? Insiders have purchased a total of 113,621 JAZZ shares in the last 24 months for a total of $11,428,763.00 bought. Which Jazz Pharmaceuticals insiders have been selling company stock? The following insiders have sold JAZZ shares in the last 24 months: Bruce C Cozadd ($2,122,970.00), Mark Douglas Smith ($49,735.59), Mary Elizabeth Henderson ($152,703.00), Neena M Patil ($1,876,440.50), Patricia Carr ($1,150,253.18), Rick E Winningham ($171,456.56), and Robert Iannone ($1,313,887.23). How much insider selling is happening at Jazz Pharmaceuticals? Insiders have sold a total of 52,206 Jazz Pharmaceuticals shares in the last 24 months for a total of $6,837,446.06 sold. Jazz Pharmaceuticals Key ExecutivesMr. Bruce C. Cozadd (Age 60)Co-Founder, Chairman & CEO Compensation: $2.44M5 recent tradesMs. Renee D. Gala (Age 52)President & COO Compensation: $1.36MMs. Patricia Carr (Age 53)Senior VP & Chief Accounting Officer Compensation: $633.4k2 recent tradesMs. Neena M. Patil J.D. (Age 49)Executive VP & Chief Legal Officer Compensation: $1.01M1 recent tradesDr. Robert Iannone M.D. (Age 57)Executive VP, Chief Medical Officer and Global Head of Research & Development Compensation: $1.19MMr. Philip L. Johnson (Age 60)Executive VP & CFO Ms. Andrea N. Flynn Ph.D.VP & Head of Investor RelationsMs. Heidi Manna (Age 53)Executive VP & Chief People Officer Dr. Jed Black M.D.Senior Vice President of Sleep & CNS MedicineMs. Samantha Pearce (Age 58)Executive VP & Chief Commercial OfficerChief Commercial Officer More Insider Trading Tools from MarketBeat Related Companies Axsome Therapeutics Insider Transactions Royalty Pharma Insider Transactions Corcept Therapeutics Insider Transactions Perrigo Insider Transactions Supernus Pharmaceuticals Insider Transactions Pacira BioSciences Insider Transactions Nektar Therapeutics Insider Transactions Omeros Insider Transactions Assembly Biosciences Insider Transactions Cumberland Pharmaceuticals Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Strategy Insiders Buy In While Analysts Predict Big UpsideThe Bottom Is in For These 3 Small-Cap Stocks Insiders Are Buying3 Catalysts Driving Plug Power’s Turnaround CaseInsider Selling Hits Market Leaders—Should You Be Worried?Insiders Spent Millions on These 3 Stocks Over the Past 2 Months This page (NASDAQ:JAZZ) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersWashington Thinks They Own Your Bank AccountWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGreen Light for These StocksGuess Who Washington Will Partner With Next? The U.S. government just made a bold $400 million move... beco...Stansberry Research | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Jazz Pharmaceuticals PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Jazz Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
